Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a written consent form agreeing to take part in the trial.
- You weigh at least 50 kg (about 110 lbs) and have a body mass index (BMI) between 18 and 40.
- You have been diagnosed with Irritable Bowel Syndrome (IBS) — specifically the constipation type, diarrhea type, or mixed type — at a moderate to severe level, based on recognised medical guidelines called the Rome Criteria.
Who may not be able to join:
- You have a known allergy to the device being tested or its components, or you have significant allergies (not including mild seasonal allergies like hay fever).
- You have a significant medical history involving the digestive system, heart, muscles or joints, hormones, blood, kidneys, liver, lungs, nervous system, immune system, mental health, or cholesterol levels that could affect the trial or put you at risk (confirm with trial site).
- You have been in hospital or had major surgery within the 30 days before screening.
- You are pregnant or have a positive pregnancy test.
- You have taken part in another clinical drug trial within the 30 days before screening.
- You have a diagnosed problem with substance use or alcohol use.
- You have other conditions that may make it hard for you to follow the trial requirements, or you are unable to participate on your own (confirm with trial site).
- You have been diagnosed with an end-stage organ disease (a serious condition where a major organ is in the final stages of failure).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +12623448468
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of intolerable treatment-related adverse events (AEs); Incidence, severity, and causal relationship of treatment-emergent AEs (TEAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.